MediPharm Launches RHO Phyto Sublingual Sprays Via Deal With Avicanna

MediPharm Labs Inc. (TSX: LABS) (OTCQX: MEDIFexpanded its product portfolio by introducing sublingual sprays as part of a deal with Avicanna Inc. (TSX: AVCN) (OTCQX: AVCNF).

The new product format would be marketed under Avicanna’s RHO Phyto medical brand.

RHO Phyto Rapid Act Sprays will be available through the Medical Cannabis by Shoppers online healthcare platform in the weeks to come.

MediPharm Labs CEO Pat McCutcheon said that Avicanna opted for MediPharm Labs …

Full story available on Benzinga.com

More MediPharm Launches RHO Phyto Sublingual Sprays Via Deal With Avicanna